Valuation: Immunovia AB

Market Cap 134M 13.79M 12.1M 11.17M 10.32M 19.56M 1.32B 19.95M 52.17M 646M 51.79M 50.66M 2.24B P/E 2026 *
-2x
P/E 2027 * -4.99x
Enterprise Value 67.26M 6.91M 6.06M 5.6M 5.17M 9.8M 662M 10M 26.14M 324M 25.95M 25.38M 1.12B EV / Sales 2026 *
21x
EV / Sales 2027 * 3.48x
Free-Float
89.3%
Yield 2026 *
-
Yield 2027 * -
1 day-2.00%
1 week+1.88%
Current month+0.31%
1 month+8.07%
3 months-9.02%
6 months-12.68%
Current year-13.83%
1 week 0.19
Extreme 0.1872
0.2
1 month 0.17
Extreme 0.173
0.24
Current year 0.15
Extreme 0.1502
0.25
1 year 0.15
Extreme 0.1502
0.97
3 years 0.15
Extreme 0.1502
4.73
5 years 0.15
Extreme 0.1502
141.5
10 years 0.15
Extreme 0.1502
298.5
Manager TitleAgeSince
Chief Executive Officer 53 2023-04-28
Chief Tech/Sci/R&D Officer 55 2024-04-28
Chief Tech/Sci/R&D Officer 54 2024-01-30
Director TitleAgeSince
Director/Board Member 72 2016-12-08
Chairman 69 2023-05-25
Director/Board Member 51 2020-12-31
Date Insider Type Main position Quantity % Market Cap.
22-11-14Buy

Chief Executive Officer

150,000 0.6628%
22-05-23Buy

Chief Executive Officer

100,000 0.4419%
22-05-20Buy

Chief Executive Officer

100,000 0.4419%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%+1.88%-58.12%-88.90% 13.79M
-0.20%-4.76%+0.92%-28.38% 15.79B
-1.77%-4.99%+29.21%+88.65% 1.62B
+1.47%-5.12%-44.03%-79.48% 1.18B
-0.07%-3.96%-30.00%+32.93% 1.09B
+0.29%-3.35%-29.97%-54.68% 614M
-2.23%-9.38%-41.11%-58.26% 537M
+1.03%+0.75%+27.64%-52.83% 453M
-0.96%+0.16%-56.32%-59.96% 377M
+0.68%-7.00%-27.67%-27.27% 323M
Average -0.38%-2.29%-22.94%-32.82% 2.2B
Weighted average by Cap. -0.23%-3.74%-3.72%-21.99%

Financials

2026 *2027 *
Net sales 3.2M 329K 288K 266K 246K 466K 31.48M 476K 1.24M 15.4M 1.23M 1.21M 53.47M 17.3M 1.78M 1.56M 1.44M 1.33M 2.52M 170M 2.57M 6.72M 83.27M 6.67M 6.53M 289M
Net income -91M -9.35M -8.2M -7.57M -7M -13.26M -895M -13.52M -35.36M -438M -35.1M -34.34M -1.52B -82M -8.42M -7.39M -6.82M -6.3M -11.95M -807M -12.19M -31.86M -395M -31.63M -30.94M -1.37B
Net Debt -67M -6.88M -6.04M -5.57M -5.15M -9.76M -659M -9.96M -26.03M -323M -25.85M -25.28M -1.12B -74M -7.6M -6.67M -6.16M -5.69M -10.78M -728M -11M -28.75M -356M -28.55M -27.92M -1.24B
Logo Immunovia AB
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
Employees
17
Date Price Change Volume
26-07-09 SEK 0.1956 -2.00% 195,164
26-07-08 SEK 0.1996 +0.91% 2,800,629
26-07-07 SEK 0.1978 +3.56% 3,526,304
26-07-06 SEK 0.1910 -1.55% 2,635,052
26-07-03 SEK 0.1940 +1.04% 1,000,987

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMMNOV Stock